today EAO Lisbon 27 September 2019
Nobel Biocare brings latest innovations to Lisbon / President of Portugal welcomes attendees at EAO 2019 / News / Floor plan / List of exhibitors / Industry / Travel
Table of contents
Array
(
[post_data] => WP_Post Object
(
[ID] => 77936
[post_author] => 0
[post_date] => 2019-09-26 20:35:50
[post_date_gmt] => 2019-09-26 20:35:50
[post_content] =>
[post_title] => today EAO Lisbon 27 September 2019
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => today-eao-lisbon-27-september-2019
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:15
[post_modified_gmt] => 2024-10-23 20:24:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/epaper/today-eao-lisbon-27-september-2019/
[menu_order] => 0
[post_type] => epaper
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77936
[id_hash] => 275a2db08f384268cc5c4a5573bfaba024077f0a7e95131b5517fa34c7705a54
[post_type] => epaper
[post_date] => 2019-09-26 20:35:50
[fields] => Array
(
[pdf] => Array
(
[ID] => 77937
[id] => 77937
[title] => today EAO Lisbon 27 September 2019.pdf
[filename] => today EAO Lisbon 27 September 2019.pdf
[filesize] => 0
[url] => https://e.dental-tribune.com/wp-content/uploads/today EAO Lisbon 27 September 2019.pdf
[link] => https://e.dental-tribune.com/epaper/today-eao-lisbon-27-september-2019/today-eao-lisbon-27-september-2019-pdf-2/
[alt] =>
[author] => 0
[description] =>
[caption] =>
[name] => today-eao-lisbon-27-september-2019-pdf-2
[status] => inherit
[uploaded_to] => 77936
[date] => 2024-10-23 20:24:09
[modified] => 2024-10-23 20:24:09
[menu_order] => 0
[mime_type] => application/pdf
[type] => application
[subtype] => pdf
[icon] => https://e.dental-tribune.com/wp-includes/images/media/document.png
)
[cf_issue_name] => EAO Meeting Lisbon September 27, 2019
[cf_edition_number] => 27102019
[contents] => Array
(
[0] => Array
(
[from] => 01
[to] => 01
[title] => Nobel Biocare brings latest innovations to Lisbon
[description] => Nobel Biocare brings latest innovations to Lisbon
)
[1] => Array
(
[from] => 02
[to] => 02
[title] => President of Portugal welcomes attendees at EAO 2019
[description] => President of Portugal welcomes attendees at EAO 2019
)
[2] => Array
(
[from] => 03
[to] => 06
[title] => News
[description] => News
)
[3] => Array
(
[from] => 08
[to] => 08
[title] => Floor plan
[description] => Floor plan
)
[4] => Array
(
[from] => 09
[to] => 09
[title] => List of exhibitors
[description] => List of exhibitors
)
[5] => Array
(
[from] => 10
[to] => 12
[title] => Industry
[description] => Industry
)
[6] => Array
(
[from] => 14
[to] => 15
[title] => Travel
[description] => Travel
)
)
)
[permalink] => https://e.dental-tribune.com/epaper/today-eao-lisbon-27-september-2019/
[post_title] => today EAO Lisbon 27 September 2019
[client] =>
[client_slug] =>
[pages_generated] =>
[pages] => Array
(
[1] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-0.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-0.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-0.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-0.jpg
[1000] => 77936-295d0c02/1000/page-0.jpg
[200] => 77936-295d0c02/200/page-0.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[2] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-1.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-1.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-1.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-1.jpg
[1000] => 77936-295d0c02/1000/page-1.jpg
[200] => 77936-295d0c02/200/page-1.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[3] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-2.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-2.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-2.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-2.jpg
[1000] => 77936-295d0c02/1000/page-2.jpg
[200] => 77936-295d0c02/200/page-2.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77938
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-3-ad-77938
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-3-ad-77938
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-3-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77938
[id_hash] => 4643ce0ca9469afeda8690dd14ec1796777b6d5724cd82721dc6a2dfe4509c12
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/acteon-group/about/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-3-ad-77938/
[post_title] => epaper-77936-page-3-ad-77938
[post_status] => publish
[position] => 23.487544483986,23.192019950125,72.597864768683,70.573566084788
[belongs_to_epaper] => 77936
[page] => 3
[cached] => false
)
)
[html_content] =>
)
[4] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-3.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-3.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-3.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-3.jpg
[1000] => 77936-295d0c02/1000/page-3.jpg
[200] => 77936-295d0c02/200/page-3.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[5] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-4.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-4.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-4.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-4.jpg
[1000] => 77936-295d0c02/1000/page-4.jpg
[200] => 77936-295d0c02/200/page-4.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[6] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-5.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-5.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-5.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-5.jpg
[1000] => 77936-295d0c02/1000/page-5.jpg
[200] => 77936-295d0c02/200/page-5.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[7] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-6.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-6.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-6.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-6.jpg
[1000] => 77936-295d0c02/1000/page-6.jpg
[200] => 77936-295d0c02/200/page-6.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[8] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-7.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-7.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-7.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-7.jpg
[1000] => 77936-295d0c02/1000/page-7.jpg
[200] => 77936-295d0c02/200/page-7.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[9] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-8.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-8.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-8.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-8.jpg
[1000] => 77936-295d0c02/1000/page-8.jpg
[200] => 77936-295d0c02/200/page-8.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77939
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-9-ad-77939
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-9-ad-77939
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-9-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77939
[id_hash] => cb88bdccb637d82305ee931873e1203f23145ad3bc0c8e44c7170880dd51ef22
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/roots-summit/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-9-ad-77939/
[post_title] => epaper-77936-page-9-ad-77939
[post_status] => publish
[position] => 60.142348754448,56.359102244389,33.807829181495,36.907730673317
[belongs_to_epaper] => 77936
[page] => 9
[cached] => false
)
)
[html_content] =>
)
[10] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-9.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-9.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-9.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-9.jpg
[1000] => 77936-295d0c02/1000/page-9.jpg
[200] => 77936-295d0c02/200/page-9.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[11] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-10.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-10.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-10.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-10.jpg
[1000] => 77936-295d0c02/1000/page-10.jpg
[200] => 77936-295d0c02/200/page-10.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[12] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-11.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-11.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-11.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-11.jpg
[1000] => 77936-295d0c02/1000/page-11.jpg
[200] => 77936-295d0c02/200/page-11.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77940
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-12-ad-77940
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-12-ad-77940
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-12-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77940
[id_hash] => 7e1f0207dc35950dc7f80c9ab64d5b89df582ad8ed61185994d276d92bc9630d
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dental-tribune.com/newsletter/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-12-ad-77940/
[post_title] => epaper-77936-page-12-ad-77940
[post_status] => publish
[position] => 4.982206405694,48.628428927681,89.679715302491,45.137157107232
[belongs_to_epaper] => 77936
[page] => 12
[cached] => false
)
)
[html_content] =>
)
[13] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-12.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-12.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-12.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-12.jpg
[1000] => 77936-295d0c02/1000/page-12.jpg
[200] => 77936-295d0c02/200/page-12.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77941
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-13-ad-77941
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-13-ad-77941
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-13-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77941
[id_hash] => 4ec2b4324ffeb6d43f0a5a94c03620bd25d52b56956924e573f4e52ccabc4d26
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dental-tribune.com
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-13-ad-77941/
[post_title] => epaper-77936-page-13-ad-77941
[post_status] => publish
[position] => 0.355871886121,0.49875311720698,99.288256227758,99.501246882793
[belongs_to_epaper] => 77936
[page] => 13
[cached] => false
)
)
[html_content] =>
)
[14] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-13.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-13.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-13.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-13.jpg
[1000] => 77936-295d0c02/1000/page-13.jpg
[200] => 77936-295d0c02/200/page-13.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77942
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-14-ad-77942
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-14-ad-77942
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-14-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77942
[id_hash] => 72f4baacbf177c6e8a8dbb1e08e4621e7a3c09039b68d11fda8ff24362289aed
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.tribunecme.com/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-14-ad-77942/
[post_title] => epaper-77936-page-14-ad-77942
[post_status] => publish
[position] => 4.982206405694,23.192019950125,70.462633451957,70.573566084788
[belongs_to_epaper] => 77936
[page] => 14
[cached] => false
)
)
[html_content] =>
)
[15] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-14.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-14.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-14.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-14.jpg
[1000] => 77936-295d0c02/1000/page-14.jpg
[200] => 77936-295d0c02/200/page-14.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77943
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-15-ad-77943
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-15-ad-77943
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-15-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77943
[id_hash] => 0c64b9a6110b2db67c2a5fe9e5b78f6faa8c3cbd4be2328c1efacb8923a33eda
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dtstudyclub.com/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-15-ad-77943/
[post_title] => epaper-77936-page-15-ad-77943
[post_status] => publish
[position] => 4.982206405694,50.374064837905,89.32384341637,42.8927680798
[belongs_to_epaper] => 77936
[page] => 15
[cached] => false
)
)
[html_content] =>
)
[16] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/2000/page-15.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/1000/page-15.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/200/page-15.jpg
)
[key] => Array
(
[2000] => 77936-295d0c02/2000/page-15.jpg
[1000] => 77936-295d0c02/1000/page-15.jpg
[200] => 77936-295d0c02/200/page-15.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 77944
[post_author] => 0
[post_date] => 2024-10-23 20:24:09
[post_date_gmt] => 2024-10-23 20:24:09
[post_content] =>
[post_title] => epaper-77936-page-16-ad-77944
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-77936-page-16-ad-77944
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-23 20:24:09
[post_modified_gmt] => 2024-10-23 20:24:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-77936-page-16-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 77944
[id_hash] => fa1c466eff7fab8210b0e819bd5e22163fb9dd2b3f4da674913ee2fbdc656654
[post_type] => ad
[post_date] => 2024-10-23 20:24:09
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/nobel-biocare-services-ag/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-77936-page-16-ad-77944/
[post_title] => epaper-77936-page-16-ad-77944
[post_status] => publish
[position] => 0.355871886121,0.24937655860349,99.288256227758,99.25187032419
[belongs_to_epaper] => 77936
[page] => 16
[cached] => false
)
)
[html_content] =>
)
)
[pdf_filetime] => 1729715049
[s3_key] => 77936-295d0c02
[pdf] => today EAO Lisbon 27 September 2019.pdf
[pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/77936/today EAO Lisbon 27 September 2019.pdf
[pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/77936/today EAO Lisbon 27 September 2019.pdf
[should_regen_pages] => 1
[pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77936-295d0c02/epaper.pdf
[pages_text] => Array
(
[1] =>
TDI0919_01-16.pdf
26
27
28
EAO 28th Annual Scientific Meeting Lisbon · 26–28 September 2019
Congress news
Interview
Dental products in focus
EAO 2019 opening ceremony promises
attendees an engaging learning atmosphere.
DTI spoke with Prof. Jocelyne Feine from
McGill University about the challenges of
implant procedures in older people.
The 2019 EAO congress offers an opportunity to see and try out the most current
innovations in implant dentistry.
» page 2
» page 4
» page 10
Nobel Biocare brings latest innovations to Lisbon
The Mucointegration concept, edentulism and a new implant system in focus at EAO.
This year, Nobel Biocare opened a
new chapter for implant dentistry
with the launch of new surfaces and
the introduction of the new Nobel
Biocare N1 implant system. Visitors
to the EAO have the opportunity on
Friday, 27 September, to view these
groundbreaking innovations and discover more about them during an engaging symposium and through interactive hands-on sessions.
Sharing their expertise at the industry symposium will be Dr Tristan
Staas and Prof. Gabor Tepper, two of
the leading implant clinicians in
Europe. They will provide exclusive
insights into how Nobel Biocare N1 is
set up to revolutionise patient care.
In order to address some of the shortcomings of current protocols, the
recently introduced system was
designed from the ground up according to biological principles and keeping patient needs in mind. Going beyond this new implant design, Nobel
Biocare N1 is also redefining site
preparation with the introduction
of the OsseoShaper, an innovative
alternative to conventional drilling
protocols. Experiences from over
24 months of clinical evaluations of
the Nobel Biocare N1 concept with
an early ambassador group have already indicated promising results in
terms of the method’s effectiveness.
Embodying the Mucointegration
concept, Nobel Biocare’s Xeal and
During the symposium, Staas and
Tepper will be joined by the worldrenowned clinician Dr Paulo Maló
from Portugal, who will demonstrate
how the NobelPro Line helps clinicians to master even the most challenging cases and treat more edentulous patients. The Nobel Biocaresponsored symposium will take place
on 27 September from 17:15 to 19:15
in the main auditorium of the Lisbon
Congress Centre. Attendance is free
with registration for the congress, and
visitors are invited to come early to secure their seats.
Attendees interested in developing their practices further can take
part in two hands-on sessions held by
Nobel Biocare on Friday. In addition
to a morning session on immediate
restorations led by Staas, Tepper will
demonstrate in the afternoon how to
achieve optimal primary stability for
immediate restorations in all bone
densities through different drill protocols.
Those who wish to attend the
workshops are invited to visit the
Nobel Biocare booth at EAO 2019 to
find out whether seats are still available.
© DTI
Well-attended Nobel Biocare booth on the first congress day.
TiUltra surfaces will be available on
the Nobel Biocare N1 implant system from the start. With the help of
their specially tailored surface
chemistry and topography, the sys-
tem’s implants and abutments will
benefit from optimised tissue integration. These new surfaces are already available for Nobel Biocare’s
On1 and Multi-unit Abutment, as
© Nobel Biocare
© Nobel Biocare
Prof. Gabor Tepper.
Dr Tristan Staas.
well as for NobelActive and NobelParallel implants, and are backed by
the latest evidence published in
Clinical Implant Dentistry and Related Research.
Nobel Biocare,
Switzerland
www.nobelbiocare.com/eao
Hall 2, Booth C15
[2] =>
TDI0919_01-16.pdf
news
President of Portugal welcomes attendees at EAO 2019
Opening ceremony promises attendees an engaging learning atmosphere.
At the opening ceremony, Dr Gil
Alcoforado, chair of the 2019 EAO
congress, officially announced that
the 28th annual scientific meeting is
underway. With attendees who have
travelled from across Europe and beyond to participate, the congress is
designed to impress and 130 speakers will be presenting a wide range
of lectures, hands-on workshops and
clinical video sessions.
EAO 2019 is being held under the
High Patronage of the President of
the Portuguese Republic, Dr Marcelo
Rebelo de Sousa. As part of this, a
video of de Sousa was played during
the opening ceremony in which he
welcomed attendees and highlighted
the country’s rich cultural heritage.
“Portugal is not just a country with a
long and important history, but one
with a bright future as well,” de
Sousa said.
“I wish you not only an unforgettable stay in this country, but also hope
that you will come back soon to get to
know our culture better,” he added.
© Brendan Day, DTI
From left: Dr Susana Noronha and Dr Gil Alcoforado, co-chair and chair, respectively, of the 2019 EAO congress, at the opening ceremony.
The President of EAO, Prof. Henning Schliephake, followed, also addressing the crowd via a pre-recorded video. The focus then turned
to Alcoforado and Dr Susana
Noronha, co-chair of the congress,
who spoke about what they hoped to
achieve under this year’s theme of
“The bridge to the future”.
Alcoforado thanked the members of the EAO congress and scientific committees, stating, “It is only
through their tireless work that we
can have such a large attendance
from such a wide range of countries”. Over 4,000 attendees overall
from more than 80 countries are expected to attend the congress, according to a press release from the
EAO.
“This is the first time the scientific meeting is taking place in Lisbon, making it an extra special occasion,” said Noronha. “I sincerely hope
that this meeting exceeds your expectations and that you all have a
fantastic congress.”
“Using cell therapy for bone regeneration is promising”
An interview with Prof. Kamal Mustafa, University of Bergen, by Franziska Beier, DTI.
Prof. Kamal Mustafa from the Department of Clinical Dentistry at the
University of Bergen in Norway is
sponsoring and leading, together
with Dr Cecilie Gjerde (University of
Bergen) and Prof. Mariano Sanz (Complutense University of Madrid), a
multicentre randomised controlled
clinical trial (RCT) on stem cell bone
building. This research is part of the
European MAXIBONE project, which
is investigating whether new jawbone prior to placement of dental implants can be grown with stem cell
technology. At EAO 2019, Mustafa
presented his research group’s work
in a session that covered the topic of
“New avenues in implant dentistry”.
He shared insights into MAXIBONE
with Dental Tribune International.
Prof. Mustafa, you gave a lecture
titled “Are stem cells the implants of
the future?” On what did you focus
during your presentation?
The potential and value of stem
cell-based therapies were explored in
the early 1990s when therapeutically
relevant tissue-supportive cells such as
mesenchymal stem cells (MSCs) were
applied for the regeneration of skeletal
tissue. This new approach using cell
therapy for bone regeneration is promising and could be used as an alternative for the classic gold standard treatment with bone grafts. The promising
data from a recent clinical trial in
11 patients in Bergen, as part of the
EU REBORNE project, has paved the
way for improved, well-designed trials
utilising stem cells for mandible augmentation and alveolar reconstruction.
MAXIBONE began at the start of 2018
and will be completed in 2021. What
is the current status of the project?
MAXIBONE aims to create personalised bone regeneration by using
2
culture-expanded autologous bone
marrow stem cells and biomaterials.
The four-year project started with
European funding of € 6 million. The
large consortium is coordinated by
Prof. Pierre Layrolle from the University of Nantes in France and me and
gathers 12 partners from six European countries, including academic
and research institutes, cell therapy
units and companies, among them
the global leader of dental implants.
In the project, an RCT of 150 patients will compare the safety and efficacy of autologous cultured stem
cells and calcium phosphate biomaterials with autologous bone grafting in
alveolar bone augmentation prior to
dental implants. In the previous European project, REBORNE, the clinical
safety of this regenerative strategy
was demonstrated in 11 patients.
How does the process work exactly?
Do the stem cells have to be autologous?
Yes, autologous cells are harvested from bone marrow, expanded
and cultured for two weeks in two
cell manufacturing centres in Germany and France. Afterwards, they
are delivered to the eight clinical centres in five European countries and
implanted in patients in combination
with biomaterials. The procedure has
been reported in our recent publication by Gjerde et al. from 2018, which
was part of the EU REBORNE project.1
Is this stem cell treatment less invasive than the standard bone transplant?
The patients tolerated the treatment very well, as described and reported in the previously mentioned
study. The data generated from the
clinical trial demonstrated that bone
28 th EAO Annual Scientific Meeting
© DTI
Prof. Kamal Mustafa presenting at EAO 2019.
marrow stem cells expanded successfully in the laboratory and, combined with synthetic bone substitute
biomaterial in the patient to augment mandibular bone, induced significant new bone formation. The regenerated bone volume was adequate for dental implant installation.
Healing was uneventful. The patients were satisfied with the aesthetic and functional outcomes. No
side effects were observed.
Could this method of bone replacement be used for other areas of the
human body?
Yes, a good example of using the
method to repair long-bone defects
has been demonstrated and reported
in a study by Gómez-Barrena et al.
from 2018.2 This interventional cli-
nical trial was also part of the
REBORNE project and performed to
evaluate the safety and feasibility of
autologous expanded MSCs from
bone marrow associated with bioceramic (microporous biphasic calcium
phosphate granules; MBCP+, Biomatlante) scaffolds in patients with longbone delayed unions and non-unions
(after a minimum of three months
from acute fracture). No severe adverse events related to the bone marrow MSCs were reported. The construct of stem cells combined with
the biomaterial which was used in
our maxillofacial clinical trial was
surgically and successfully delivered
to the non-unions, and 26 of 28
treated patients were found to be radiologically healed at one year after
treatment.
References:
1
Gjerde C, Mustafa K, Hellem S, Rojewski M,
Gjengedal H, Yassin MA, Feng X, Skaale S,
Berge T, Rosen A, Shi XQ, Ahmed AB, Gjertsen BT, Schrezenmeier H, Layrolle P. Cell therapy induced regeneration of severely atrophied
mandibular bone in a clinical trial. Stem Cell
Res Ther. 2018 Aug 9;9(1):213. doi: 10.1186/
s13287-018-0951-9.
2
Gómez-Barrena E, Padilla-Eguiluz NG, Avendaño-Solá C, Payares-Herrera C, Velasco-Iglesias
A, Torres F, Rosset P, Gebhard F, Baldini N, Rubio-Suarez JC, García-Rey E, Cordero-Ampuero J,
Vaquero-Martin J, Chana F, Marco F, García-Coiradas J, Caba-Dessoux P, de la Cuadra P, Hernigou P, Flouzat-Lachaniette CH, Gouin F, Mainard
D, Laffosse JM, Kalbitz M, Marzi I, Südkamp N,
Stöckle U, Ciapetti G, Donati DM, Zagra L, Pazzaglia U, Zarattini G, Capanna R, Catani F. A
multicentric, open-label, randomized, comparative clinical trial of two different doses of expanded hBM-MSCs plus biomaterial versus iliac crest autograft, for bone healing in nonunions after long bone fractures: study protocol.
Stem Cells Int. 2018 Feb 22;2018:6025918. doi:
10.1155/2018/6025918.
[3] =>
TDI0919_01-16.pdf
© DTI
news
“Implant therapy in the aesthetic zone
is fraught with pitfalls”
An interview with Dr Homa Zadeh, periodontist from Los Angeles, California, by Franziska Beier, DTI.
With his presentation, Dr Homa
Zadeh contributed to a session that
considered the theme “Should we
avoid implants in the aesthetic zone?”
in the EAO 2019 scientific programme.
He is a diplomate of the American
Board of Periodontology and a past
President of the Western Society of Periodontology. In a short interview with
Dental Tribune International, Zadeh
discussed the challenging aspects of
placing implants in the aesthetic zone
and the accompanying expectations of
the patient.
tion has to be based on both anatomical and prosthetic guidelines. By recognising all of these elements of risk, it is
possible to manage them by proper decision-making and to maximise the
predictability of the outcome.
How do patients’ expectations of implants in the aesthetic zone vary from
their expectations of implants elsewhere in the oral cavity?
Any therapy in the anterior maxilla has very little leeway for error be-
A packed audience listens to Dr Zadeh’s presentation.
cause the outcome is directly visible by
the patient and others. Implant therapy in the aesthetic zone is extra chal-
lenging, because the outcome is a reflection of both the surgical and the
prosthetic therapy performed.
AD
IT’S TIME FOR
EFFICIENT
3D DIAGNOSIS
© DTI
Dr Homa Zadeh delivering his lecture in the
auditorium of the Lisbon Congress Centre.
You gave a lecture titled “Placing implants in the aesthetic zone”. On what
topics did you focus during your presentation?
My presentation focused on the
decision-making process as the most
important aspect of implant therapy in
the aesthetic zone. There are dozens of
decisions that have to be made that
can affect the outcome. The bases on
which those decisions are made were
the focus of my presentation.
What are the pros and cons of implants in the aesthetic zone, and what
are the specific challenges of placing
implants in the aesthetic zone?
Implant therapy in the aesthetic
zone is fraught with pitfalls, such
as the variability of healing of tooth
extraction sockets, as well as the
variability of peri-implant mucosal
changes. Implant installation is far
more challenging in the anterior maxilla compared with other oral sites,
whether implants are placed in extraction sockets or in healed sites. The combination of biological variability in outcomes, as well as technical challenges,
can increase the likelihood of a negative outcome. However, rather than
avoiding implants in the aesthetic zone
altogether, it is important for clinicians
to perform a thorough risk assessment
in order to understand the risk factors
and risk indicators that can influence
the outcome. Important risk factors
discussed included the alveolar bone
phenotype of the extraction sockets
(i.e. thin is less than 1 mm and thick
greater than 1 mm) and the mucosal
phenotype. Also, the 3D implant posi-
Hall 10.2
3D diagnosis
is more accessible
than ever with a
smart and compact
solution
-
X-Mind® prime is manufactured by Dental X-ray Compagny and distributed by ACTEON.
For dental professional use only.
DE GOTZEN ® A Company of ACTEON® Group
Via Roma 45 21057 Olgiate Olona VA ITALY
Tel + 33 39 0331 376760 Fax + 39 0331 376763
E-mail: info@acteongroup.com www.acteongroup.com
28 th EAO Annual Scientific Meeting
3
[4] =>
TDI0919_01-16.pdf
news
“We usually think of rehabilitation as the responsibility of the clinician”
An interview with Prof. Jocelyne Feine, McGill University, by Franziska Beier, DTI.
As the percentage of older people
in the population is growing, the
number of elderly people depending
on dental implants is increasing.
Dental Tribune International spoke
with Prof. Jocelyne Feine from the
Faculty of Dentistry at McGill University in Montreal in Canada about
the challenges of implant procedures in older people and how patients can contribute to the healing
process. On 26 September, Feine
spoke about the topic at the EAO
2019 congress.
Prof. Feine, you gave a lecture on
identifying the best treatment op-
tions for older patients. On what topics did you focus during your presentation?
I shared with the audience the
factors that edentate older patients
consider to be important regarding
their prostheses. With that information, consideration of the most appropriate types of prostheses and number of implants was discussed.
Why is implant treatment in elderly
patients possibly more challenging?
Elderly adults tend to have many
chronic conditions and often take numerous medications that can interfere with the osseointegration pro-
© DTI
Prof. Jocelyne Feine speaking about challenges of placing dental implants in older patients.
All pictures: © DTI
Impressions of EAO 2019
4
28 th EAO Annual Scientific Meeting
cess. They may also have physical restrictions that may make maintenance of oral hygiene difficult.
How can elderly patients who
have received dental implants contribute to the rehabilitation process?
This is an interesting question,
since we usually think of rehabilitation as the responsibility of the clinician. However, unless the patient is
motivated and able to maintain his or
her oral hygiene, treatment will fail.
Thus, it is important for clinicians to
assess their older patients’ motivation, as well as their ability to clean
their mouths, the abutments, etc.
[5] =>
TDI0919_01-16.pdf
news
New hydrogel shows promise
in dental and craniofacial tissue engineering
Researchers from the University of
California, Los Angeles School of Dentistry have developed a new hydrogel
that shows high porosity and effectiveness in promoting tissue repair
and regeneration. The study findings
suggest that the next generation of
hydrogel systems could greatly improve current biomaterial-based therapeutics to repair bone defects in the
near future.
Hydrogels are biomaterials that
are made up of a 3D network of polymer chains. Owing to the network’s
ability to absorb water and its structural similarities to living tissue, it
can be used to deliver cells to defective areas to regenerate lost tissue.
However, the small pore size of hydrogels limits the survival of the transplanted cells, their expansion and
new tissue formation, making this
less than ideal for regenerating tissue.
Injectable combinations of living
cells and bioactive molecules using
hydrogels would be a preferred medical application to treat unhealthy or
damaged areas of the body rather
than more invasive surgery.
Future research is planned to investigate how the physical properties
of nanocomposite hydrogels affect
the migration of cells and their function, as well as the formation of blood
vessels.
“Our nanocomposite hydrogel
system will be useful for many applications, including therapeutic delivery, cell carriers, and dental and craniofacial tissue engineering,” concluded Lee.
The study, titled “Microporous
methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel
for bone tissue engineering”, was
published in Nature Communications.
AD
© University of California, Los Angeles
Microscopic image of regenerated bone.
One material that has been of interest in the field of biomaterials is
naturally occurring mineral clay. It
has become an ideal additive to medical products and has no reported
negative effects. It has been shown to
be biocompatible and is readily available.
Clay is structured in layers and its
surface has a negative charge. This
unique layered structure and charge
were important to the research team,
as the hydrogel they used had a positive charge. When the hydrogel was
inserted into the clay layers through
the process of intercalation chemistry,
the end result was a clay-enhanced hydrogel with a much more porous structure, improving bone formation.
Once the researchers had produced the clay-enhanced hydrogel,
they used the process of photoinduction to turn their new biomaterial into
a gel, which would make it easier for it
to be injected into the mouse model.
The mouse model had a nonhealing
skull defect into which the researchers
injected the clay-enhanced hydrogel.
After six weeks, they found that the
model showed significant bone healing
through its own naturally occurring
stem cell migration and growth.
When asked by Dental Tribune
International what the study results
mean for dentistry and, specifically,
for implantology, lead author Dr Min
Lee, Professor of Biomaterials Science at the university answered:
“This research will help us develop
the next generation of hydrogel systems with high porosity for better
bone repair and could greatly improve current bone graft materials.”
The largest annual
world Dental Meeting!
Waiting for you in 2020!
/ciosp
_ciosp
www.ciosp.com.br
atendimento.congressista@apcdcentral.com.br
28 th EAO Annual Scientific Meeting
5
[6] =>
TDI0919_01-16.pdf
news
“Antibiotics are often overprescribed in an arbitrary manner
and mostly unnecessarily in dentistry”
An interview with Dr Ismael Khouly, New York University, by Franziska Beier, DTI.
The use of antibiotics remains a
controversial topic. A recent study1
investigated the necessity of antibiotics for the prevention of dental implant infections. Lead author Dr Is© Ismael Khouly
mael Khouly, Associate Director of
Periodontology and Implant Dentistry at Bluestone Center for Clinical Research at the New York University College of Dentistry in the
US and his colleagues found that
the prophylactic use of antibiotics
has no influence on the prevalence
of post-surgical dental implant complications in patients who are
healthy overall. Khouly was so kind
as to answer DTI’s questions on the
topic.
Dr Khouly, why did you focus on this
topic for your study1?
We decided to focus our systematic review on this topic because of
the absence of current clinical guidelines for antibiotic prophylaxis in
dental implant placement procedures, the misuse and overuse of antibiotics, and the risks associated
with their prescription.
While reviewing the medical literature, I noticed that existing guidelines on antibiotic prophylaxis in surgery, such as hip and knee arthroplasty, are often based on postoperative infection. Therefore, we decided
to focus our systematic review on antibiotic prophylaxis to prevent surgical wound infection in dental implant
surgeries rather than to prevent implant failure only.
Furthermore, we investigated
whether any specific antibiotic regimens with regard to antibiotic compound, dosage and dosing schedule
were justified for specific evidence-based clinical guidelines. Our
goal was to obtain more information
and help clinicians to identify when
to use antibiotics, responsibly, in dental implant placement procedures, to
identify those clinical situations
where antibiotics are recommended,
as well as to choose the right antibiotic at the right dose and for the right
duration.
Would you say that antibiotics are
generally prescribed too often?
Unfortunately, antibiotics are often overprescribed in an arbitrary
manner and mostly unnecessarily in
dentistry, according to a recent study
published in JAMA Network Open.2
This is important because around
10 % of the antibiotics used in the US
are prescribed by dentists. Therefore,
we must develop clinical guidelines
for the rational use of antibiotics
based on evidence and reduce the
misuse of antibiotics.
How can dentists be made aware of
this situation?
Every clinician involved in dental implant surgery procedures
should take care not to overlook confounding variables while prescribing
antibiotics in dental implant placement surgeries. Clinicians should understand that postoperative complications in implant dentistry, such as
postoperative infection and implant
failure, are most likely multifactorial
and involve different risk factors
which could be related to the clinician, the environment or the patient.
Moreover, early implant failure may
be caused by reasons other than postoperative infection, such as confounders from the surgical procedure as
stated in a study by the International
Team for Implantology Antibiotic
Study Group.3
What would you recommend to dentists regarding antibiotic prescriptions for future implant surgeries?
Bearing in mind the limitations of
our systematic review, it seems that
antibiotic prophylaxis may not prevent postoperative infections after
dental implant placement procedures. However, and as stated in our
study, “It is our recommendation that
until such evidence becomes available, clinicians evaluate the benefits
(or lack thereof) of antibiotic prophylaxis for each patient given medical
history and surgical complexity and
seriously consider results of the present paper for overall healthy patients,
as well as risks associated with administration of antibiotics.”1
References:
1
Khouly I, Braun RS, Chambrone L. Antibiotic
prophylaxis may not be indicated for prevention of dental implant infections in healthy patients. A systematic review and meta-analysis.
Clin Oral Investig. 2019 Apr;23(4):1525–53.
2
Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE,
Hershow RC, Perez RI, McGregor JC, Evans CT.
Assessment of the appropriateness of antibiotic
prescriptions for infection prophylaxis before
dental procedures, 2011 to 2015. JAMA Netw
Open. 2019 May 31;2(5):e193909. doi: 10.1001/
jamanetworkopen.2019.3909.
3
Tan WC, Ong M, Han J, Mattheos N, Pjetursson
BE, Tsai AY, Sanz I, Wong MC, Lang NP; ITI Antibiotic Study Group. Effect of systemic antibiotics on clinical and patient reported outcomes
of implant therapy—a multicenter randomized
controlled clinical trial. Clin Oral Implants Res.
2014 Feb;25(2):185–93.
Eggshells may help heal teeth and bones
Crushed or pulverised eggshells
have many practical uses. They can
be used as a natural calcium supplement, a coffee sweetener, a treatment
for minor skin irritations and a nontoxic abrasive cleaner, or for garden
compost and pest control. Recently,
researchers also investigated the use
of eggshells as material for bone
grafts and for regenerating cartilage,
teeth and tendons.
The study, led by Dr Gulden
Camci-Unal of the Department of
Chemical Engineering at the University of Massachusetts Lowell, found
an innovative use for powdered eggshells—which are composed mainly of
calcium carbonate crystals—for engineering bone tissue that could lead to
improved results for bone repair and
healing. The researchers used microscopic eggshell particles to reinforce
gelatin-based hydrogels, which then
served as stable 3D scaffolds for
growing osteoblasts.
Camci-Unal said that this technique can be applied to treat and re-
pair bones in patients who have suffered injuries due to aging or cancer
and other diseases, as well as those
injuries resulting from accidents or
© Avelina/Shutterstock.com
combat situations. The 3D structure
can be used to grow not only bone for
bone grafts but also cartilage, teeth
and tendons, she added.
“This is the first study that uses
eggshell particles in a hydrogel matrix for bone repair,” noted CamciUnal. “We have already filed a patent application for it earlier this
year. We are very excited about our
results, and we anticipate a lot of impactful applications of our invention.”
The study, titled “Eggshell particle-reinforced hydrogels for bone tissue engineering: An orthogonal approach”, was published in Biomaterials Science.
Eggshells could play a role in bone grafting and other medical procedures.
New research could help to tackle tooth loss and regeneration
New research has shed light on
the mechanism behind the formation
of the periodontal ligament. The researchers found that the Notch signalling pathway, which is known to
be activated in stem cells and cancer,
is instrumental in periodontal ligament development. The findings will
help scientists work towards regenerating the tissues that support
teeth.
The study was conducted by researchers from the universities of
Plymouth and Geneva and focused
on rat and mouse molar teeth. They
found that lamin A, a cell nuclear
protein, is a direct target of the Notch
pathway. Lamin A is best known for
its mutated form progerin, which
causes the fatal “early ageing” disease called progeria syndrome. By
6
© University of Plymouth
A recent study has examined regulation of periodontal ligament maturation at the molecular level.
28 th EAO Annual Scientific Meeting
uncovering the involvement of
lamin A in periodontal ligament formation, the scientists have gained a
better insight into how molecules
function during tissue regeneration
and how the process could be affected during disease.
“The periodontal ligament starts
to properly hold the tooth in the jawbone when a tooth breaks out and
becomes functional,” said co-author
Dr Bing Hu, Associate Professor in
Oral and Dental Health Research at
the University of Plymouth’s Peninsula Dental School. “Understanding
the mechanisms of how periodontal
ligaments develop and the molecules
that assist the tissue becoming mature is really important for our understanding of tissue regeneration
and repair,” he continued. “The next
steps are for us to see if and how the
molecules we have identified in this
study can be translated into a human-only model and, in turn, how
they are affected in both healthy and
diseased conditions.”
“We believe that our findings are
an important stepping stone to better dental treatments in situations
involving the periodontal ligament,
such as gum disease (periodontitis),
tooth restoration by dental implants
or orthodontic tooth movement,”
said co-author Dr Balázs Dénes, a
doctoral student at the University of
Geneva.
The study, titled “Notch coordinates periodontal ligament maturation through regulating lamin A”,
was published in the Journal of
Dental Research.
[7] =>
TDI0919_01-16.pdf
[8] =>
TDI0919_01-16.pdf
floor plan
Hall 2
Hall 1
E04
HOSPITALITY
SUITE 1
HOSPITALITY
SUITE 2
HOSPITALITY
SUITE 3
O
TO
LL
HAL
2
B60
A25
TO E-POSTERS
ZONE
C51
B62
F07
D27
A26
C49
B54
D28
F09
F11
G06
G08
G09
G07
D23
F18
F20
F19
F21
G10
G14
HOSPITALITY
SUITE 5
H08
H06
G11
G17 - G19
G13
G21
G15
H12
D22
A22
D21
B48
F15
F13
HOSPITALITY
SUITE 4
E05 - E07
D26
D25
B43
E01
EAO CHANNEL
STUDIO
H03
H09
H11
H13
ASSOCIATIONS
CORNER
D20
C35
A20
D19
B42
H15
D18
H17
C38
C33
A18
D16
B39
C31
B38
TO
HALL
1
A15
D14
C30
B35
A11
TO HALL 3
TO FIRST FLOOR
CONFERENCE ROOMS
D10
C28
A10
A09
C27
B31
Hall 3
D07
D08
A08
TO HALL 1
B28
C25
K01
D04
B22
C20
D03
K02
A04
B17
D01
B18
A01
C12
C15
A02
I01 J02
J01–K03
K04
I03 J04
J03–K05
K06
ROOM 9
D02
ROOM 10
B14
Mezzanine
Mezzanine
C08
B07
B08
B10
C09
L04
C07
C06
B01
B02
B04
C05
L06
C03
TO
E-POSTERS
ZONE
REGISTRATION
I05 J06
TO
REGISTRATION
K12
ENTRANCE
HALL 1
HALL 3
HALL 2
ENTRANCE
This floor plan is a reproduction of the floor plan by the EAO. Changes or modifications may occur.
8
28 th EAO Annual Scientific Meeting
L07
TO
HANDS-ON SESSIONS ROOMS 11, 12, 13
[9] =>
TDI0919_01-16.pdf
list of exhibitors
Company
Hall/Booth
3
Company
Hall/Booth
D
3SHAPE
2/B35
A
DATUM DENTAL
1/G17–G19
Company
Hall/Booth
I-RES GROUP
2/B18
3/K12
JDENTALCARE
ACE SURGICAL SUPPLY COMPANY
1/C07
DENTAL RATIO
2/C06
K
ACTEON GROUP
1/H03
DENTIUM
2/B17
KLOCKNER IMPLANT SYSTEM
DENTSPLY SIRONA
2/C27
L
ALFA GATE
3/J01–K03
ALPHA BIOTECH
2/B14
DIO IMPLANT
2/C35
LIFENET HEALTH
AMERICAN DENTAL SYSTEMS
1/H13
DR-KIM CO.
2/D02
M
ANTHOGYR
2/D23
E
ASEPTICO
2/C07
EMS ELECTRO MEDICAL SYSTEMS
AVINENT IMPLANT SYSTEM
2/D10
B
Q
2/B01
2/D04
2/B02
1/H17
R
Company
Hall/Booth
SUNSTAR
2/A22
SURGIDENT CO.
3/L04
SWEDEN & MARTINA
3/I05
REGEDENT
2/A08
T
RHEIN’83
1/G08
THOMMEN MEDICAL
2/B22
RUETSCHI TECHNOLOGY
1/H06
TI-OSS OCTABONE
2/D28
TRATE
2/B48
2/B38
S
S.I.N. IMPLANTS
2/D27
TRI DENTAL IMPLANTS
MALO CLINIC
2/A10
SAEYANG MICROTECH CO.
1/F21
TRUABUTMENT
1/F18
MAXILLARIS
3/K02
SANHIGIA THINK SURGICAL
2/B60
U
EURONDA
2/A18
MECTRON
1/G15
SAUDE ORAL
3/J04
UBGEN
2/D01
EXAKTUS
2/B08
MEDENTIKA
2/HS2
SHINHUNG CO.
2/A04
USTOMED INSTRUMENTE
1/H09
2/A02
MEDENTIS MEDICAL
1/H11
SHINING 3D TECH CO.
2/D21
V
SIC INVENT
2/D25
VERSAH
B&B DENTAL IMPLANT COMPANY
2/D08
EXOCAD
BEGO IMPLANT SYSTEMS
2/B43
F
BEIJING YHJ SCIENCE
Hall/Booth
QUINTESSENCE PUBLISHING
J
DENTAL PRO
Company
MEDICAL INSTINCT
1/E05–E07
3/J02
FORESTADENT IMPLANTS
2/D18
DEUTSCHLAND
1/H08
SK BIOLAND CO.
2/A25
W
2/B04
MEDIDENT ITALIA
2/D26
SOUTHERN IMPLANTS
2/A26
W&H GROUP (W&H + OSSTELL)
MEDIT
1/E01
SPEMD
3/K04
Y
AND TRADE CO.
3/I03
FOTONA
BIEN-AIR DENTAL
1/G14
G
BIOHORIZONS CAMLOG
2/C25
GEISTLICH BIOMATERIALS
2/C31
MEGAGEN IMPLANT
2/A01
SPERO
3/K06
YUNYI MEDICAL DEVICE CO.
BIOMEDICAL PRF-BRGF
3/I01
GLOBAL D
2/D07
MEISINGER
1/F07
SPPI
3/K01
Z
BIOMEDICAL TISSUES
2/A09
H
META
2/B07
S-TECH
2/D22
ZEST DENTAL SOLUTIONS
BIONNOVATION BIOMEDICAL
2/D20
HU-FRIEDY
MIS
2/C28
STOMA/STORZ AM MARK
1/G11
ZIBONE
1/G09
BIOTECH DENTAL
1/G10
I
STRAUMANN
2/HS2
ZIMMER BIOMET
2/C30
BLUE M
1/G06
IBI SA SMARTBONE
2/D19
NEODENT
2/C49
BOTISS BIOMATERIALS
2/A15
IBS IMPLANT
2/C51
NEOSS
1/E04
IMPLACIL DE BORTOLI
1/F15
NIBEC CO.
2/B42
NOBEL BIOCARE SERVICES
2/C15
BREDENT GROUP
2/D14–D16
2/A20
N
BRESMEDICAL
1/G13
IMPLANCE DENTAL
BTI BIOTECHNOLOGY INSTITUTE
2/B39
IMPLANT SYSTEM
2/C08
NOVABONE PRODUCTS
1/F11
IMPLANTSWISS I-SYSTEM
2/C12
NSK
2/B10
NUCLEOSS
2/D03
NYU DENTISTRY
1/H12
C
CARESTREAM DENTAL
2/C33
INTERNATIONAL TEAM
CLARONAV
2/C09
FOR IMPLANTOLOGY
CURAPROX
1/F19
INVIBIO BIOMATERIAL SOLUTIONS 2/B62
1/F20
about the publisher
International Office/Headquarters
Dental Tribune International GmbH
Holbeinstraße 29, 04229 Leipzig, Germany
Phone: +49 341 48474-302
Fax:
+49 341 48474-173
E-mail: info@dental-tribune.com
Internet: www.dental-tribune.com
Production Executive
Gernot Meyer
Advertising Disposition
Marius Mezger
Production
Matthias Abicht
Publisher/Chief Executive Officer
Torsten Oemus
Chief Financial Officer
Dan Wunderlich
Director of Content
Claudia Duschek
Managing Editor
Franziska Beier
Assistant Editor
Brendan Day
Business Development & Marketing Manager
Alyson Buchenau
Sales & Production Support
Puja Daya, Hajir Shubbar, Madleen Zoch
today will appear at the 28th EAO Annual Scientific Meeting
in Lisbon, 26 –28 September 2019. The newspaper and all
articles and illustrations therein are protected by copyright.
Any utilisation without prior consent from the editor or publisher is inadmissible and liable to prosecution. No responsibility shall be assumed for information published about
associations, companies and commercial markets. General
terms and conditions apply; legal venue is Leipzig, Germany.
© 2019, Dental Tribune International GmbH.
All rights reserved. Dental Tribune International makes every
effort to report clinical information and manufacturer’s
product news accurately, but cannot assume responsibility
for the validity of product claims, or for typographical errors.
The publishers also do not assume responsibility for product names, claims, or statements made by advertisers.
Opinions expressed by authors are their own and may not
reflect those of Dental Tribune International.
O
OMNIA
2/B31
ORTHOCELL
2/C05
OSSTELL
2/C20
OSSTEM IMPLANT
2/C38
OSTEOBIOL BY TECNOSS
2/B28
OSTEOGENICS BIOMEDICAL
1/F13
OSTEOLOGY FOUNDATION
2/A11
OXY IMPLANT
2/C03
P
PENGUIN RFA
1/F09
PLANMECA
2/B54
PURGO BIOLOGICS
1/H15
2/C20
1/G21
3/J05–K05
AD
is coming to
PRAGUE
21–24 May 2020
Prague, Czech Republic
www.ROOTS-SUMMIT.com
28 th EAO Annual Scientific Meeting
9
[10] =>
TDI0919_01-16.pdf
industry
PIONEERING TECHNOLOGY 2019: X-MIND PRIME 3D IS THE PERFECT PROFESSIONAL SOLUTION
X-Mind prime is the latest addition to ACTEON’s CBCT digital imaging product line. It blends cutting-edge technology with ease of
use in a compact design. With X-Mind
prime 3D, high-tech is at your fingertips with tools for accurate diagnosis
and complete treatment planning.
It is a lightweight and compact system that can fit into any dental office.
ACTEON is showcasing its new product at EAO 2019.
X-Mind prime is a complete solution that combines 2D and 3D technologies. Using a single sensor, practitioners can quickly and easily
switch between modes. With these
features, X-Mind prime offers a wide
range of possible examinations,
24 options for panoramic and 32 for
CBCT, covering many clinical applications, including implantology, endodontics, and temporomandibular
joint and sinus imaging. Practitioners can also scan 3D objects such as
plaster models and silicone impressions, opening up new possibilities.
Hence, all dental practices can now
offer their patients 3D imaging and
expand their clinical applications
with this solution.
These are just a few of the possibilities that X-Mind prime offers. Furthermore, when equipped with the
ACTEON Imaging Suite precision
software, which is compatible with
both Windows and macOS operating
systems, the unit provides advanced
functionality. Intuitive image han-
ensures an accurate, reliable and
rapid treatment.
X-Mind prime is a lightweight
and compact system, and consequently, this equipment can fit into
Delivered preassembled to the office
and installed by a single specialist
technician, the unit is up and running in under an hour, not interfering with the daily workload.
dling and state-of-the-art tools simplify implant planning. In addition,
customised reports improve communication and the unique solution facilitates diagnosis. For patients, this
very small spaces. However, the ingenuity of X-Mind prime does not
end there! With its intelligent wallmounted system, the unit adapts easily to all office space configurations.
Using X-Mind prime provides
true comfort to practitioners in their
daily practice. The unit is also remarkably easy to use: the patient is
positioned face to face with the prac-
titioner while in operation, and the
simplified control panel located under the chin support allows simple
and accurate handling. Automatic
chin support recognition, based on
the type of operation selected, allows
error-free patient positioning. This
represents significant time-saving.
Acquiring X-Mind prime is more
than just buying a device. ACTEON
believes the quality of its customer
service is every bit as important as
the quality of its products. The group
provides personalised support based
on each practitioner’s needs and
specific situation. A pioneer in the
manufacturing of innovative and
less invasive dental imaging solutions, ACTEON is expanding its panoramic and CBCT product line with
X-Mind prime. The device is an all-inone solution that integrates 2D and
3D imaging and combines all of the
group’s high-tech expertise with its
service quality.
Attendees of EAO 2019 are invited to discover the new X-Mind
prime 3D at ACTEON’s booth.
ACTEON, France
www.acteongroup.com
Hall 1, Booth H03–H05
OSTEOBIOL GTO: A NEW STEP TOWARDS EXCELLENCE IN BIOMATERIALS
At the beginning of this year,
Tecnoss Dental, a leading biomaterials manufacturer based in Italy,
launched a new bone substitute
which combines innovative and advanced biotechnology, providing implantologists and periodontists with
a grafting solution with improved
surgical handling and predictable
regenerative results. OsteoBiol GTO
is endowed with all the characteristics of the ideal biomaterial for bone
regeneration. This pioneering product is able to promote the three biological processes which guide bone
regeneration: new bone apposition,
neo-angiogenesis and progressive
resorption of the scaffolding material, in order to promote adequate
new bone formation. Tecnoss is
showcasing GTO at this year’s EAO
congress.
GTO is a dual-phase biomaterial,
because its granules contain both
mineral and organic components.
The preservation of collagen within
the original xenogeneic cortical and
cancellous bone matrix induces a
physiological biological response by
the patient’s bone tissue. Collagen
has several significant advantages
for bone regeneration, all scientifically well documented: it stimulates
mesenchymal stem cell differentiation into osteoblasts, it is chemotactic, and it stimulates neo-angiogenesis and the absorption and subsequent release of growth factors.
All these important biological benefits have determined the scientific
rationale behind Tecnoss’s 20-yearlong research and development effort to produce a full range of collagenated dual-phase bone substitutes.
The development of GTO is the
last step of the process of continuous
improvement by Tecnoss, starting
with Apatos Cortical, a very osteoconductive but slowly resorbed scaffolding biomaterial. The first real
breakthrough innovation has been
Gen-Os, which is the precursor of all
the dual-phase products. The outstanding OsteoBiol mp3 then followed as the first pre-hydrated bone
substitute, packed in a ready-to-use
syringe. In 2016, OsteoBiol TSV Gel,
the thermosensitive viscosity resorbable gel which is used to create a
sticky bone mix with Gen-Os, was
launched. GTO combines all of the
company’s experience and expertise
in a unique product which is extremely versatile and achieves outstanding biological performance.
GTO has an ideal viscosity, which
means that it is very sticky and easily adaptable to the recipient site,
making it a great option for treating
various types of complex bone lesions. Its syringe formulation means
that it is ready to use and is directly
injectable into bone defects, making
its handling easy and quick. GTO has
been conceived as a universal biomaterial for use with OsteoBiol Evolution membranes or Lamina to protect
the graft. Its stickiness and stability
are useful properties for horizontal
augmentation procedures (e.g. twowall defects, where the crest is resorbed) and for socket preservation
cases with compromised buccal
plates. During sinus lifting, GTO can
be applied directly through the bony
window, helping the stabilisation of
implants in case of immediate placement. GTO can also be successfully
used to treat peri-implant lesions,
dehiscences and severe intra-bony
defects.
The product is already available
in all EU countries and in other European markets where the OsteoBiol
product line is distributed. For further information, visit www.osteobiol.com/contact.
Tecnoss, Italy
www.osteobiol.com
Hall 2, Booth B28
10
28 th EAO Annual Scientific Meeting
[11] =>
TDI0919_01-16.pdf
industry
AESTHETICS REIMAGINED WITH INVERTA IMPLANT
The INVERTA implant represents
the latest breakthrough technology
from Southern Implants and is designed for optimising aesthetics in
maxillary anterior extraction socket
sites. At EAO 2019, the company is
showcasing its newest product.
The INVERTA implant features
a novel Body-Shift design that addresses challenges many clinicians
face with immediate anterior implant procedures. The innovative
design of the inverted coronal segment of the implant allows for a
chamber for bone growth to be created, thereby enhancing the ability
to obtain natural-looking aesthetics.
The wider apical portion allows the
implant to achieve the primary stability critical in immediate placement.
INVERTA also incorporates
proven features from Southern Implants’ other implant product lines,
such as its SInergy Surface with
decades of clinical research and
high-strength Grade 4 pure titanium,
which provides exceptional fatigue
strength. The new implant is available with the popular deep conical internal and external hex connections.
For treatment flexibility, INVERTA is
available in a straight configuration
and 12° Co-Axis, the latter offering
built-in Subcrestal Angle Correction
pected to be released throughout
2019 and beyond:
• Chu SJ, Östman PO, Nicolopoulos
C, Yuvanoglu P, Chow J, Nevins M,
Tarnow DP. Prospective multicenter clinical cohort study of a
novel macro hybrid implant in
maxillary anterior postextraction
sockets—1-year results. Int J Perio-
dontics Restorative Dent. 2018;
38(Suppl):17–27.
• Chu SJ, Tan-Chu JH, Levin BP, Sarnachiaro GO, Lyssova V, Tarnow DP.
A paradigm change in macro implant concept: inverted body-shift
design for extraction sockets in the
esthetic zone. Compend Contin Educ
Dent. 2019 Jul/Aug;40(7):444–52.
• Nevins M, Chu SJ, Jang W,
Kim DM. Evaluation of an innovative hybrid macrogeometry
dental implant in immediate extraction sockets: a histomorphometric pilot study in foxhound
dogs. Int J Periodontics Restorative Dent. 2019 Jan/Feb;39(1):
29–37.
For more information during
EAO 2019, please visit the company’s
booth.
Southern Implants,
South Africa
www.southernimplants.com
Hall 2, Booth A26
AD
PRAGODENT
2 7 th I N T E R N AT I O N A L D E N TA L FA I R
3–5 October 2019
NEWLY
IN PARALLEL
without using angled abutments, resulting in greater facial soft-tissue
volume and providing ideal screwretained restorative options.
Dr Pär-Olov Östman, a respected
opinion leader who practises in
Falun, Sweden, commented on the
innovative implant design: “To be
able to use INVERTA implants in aesthetically challenging cases gives me
a predictable outcome with limited
buccal recession and healthy soft
tissue.”
The following clinical research
articles on INVERTA have been published and more articles are ex-
LETŇANY
PRAGUE
4–5 October 2019
pragodent.eu
ORGANISER
PLACE OF THE EVENT
MAIN PROFESSIONAL PARTNER
OFFICIAL CARS
28 th EAO Annual Scientific Meeting
11
[12] =>
TDI0919_01-16.pdf
industry
CLARONAV PRESENTS STATE-OF-THE-ART NAVIGATION FOR DAILY PRACTICE AT EAO 2019
Similarly to the way in which a
GPS system guides a driver, Navident by ClaroNav guides clinicians
by using the CBCT image as a map. It
offers surgeons an easy-to-use, accurate, highly portable and affordable
means of planning restorations and
implant placements.
With Navident 2, clinicians will
no longer need to do a special extra
scan. They can use the diagnostic
scan already available for the patient. The stress of stent making is
also gone because a stent is no longer
required. Trace and Place (TaP) is
a game-changing development for
dynamic navigation. With TaP, the
Navident workflow is streamlined, efficient, user-friendly and seamlessly
integrated into the daily practice.
“Trace and Place is a real tipping
point for dynamic navigation guidance,” said user Dr George Mandelaris, a periodontist from Chicago in
the US. “It has streamlined and simplified the workflow in both the diagnostic and surgical phases to allow state-of-the-art technology to be
an everyday component of my surgical implant practice. I cannot imagine going back!”
Implantology specialists who
have used Navident 2.0 experienced negligible operator stress, improved time efficiency and an increase in patient acceptance. The
Simplified Workflow
with TaP (Trace Registration)
... which can be performed in a single appointment
Plan
Trace
Place
Plan restorative-driven
implant placement on a
laptop
Register the CBCT
scan to the patient by
selecting 3-6 landmarks
on the screen and tracing
around those landmarks
in the mouth with a tracer
tool.
Drill and place the
implants under dynamic
guidance
The restoration and implant
placement plan is created
using the CT image data,
optionally with added
intraoral scans or any
other surface data (STL
files). The plan can be
modified at any time, even
during surgery. Navident
is compatible with any
implant size and type
available on the market.
The registration process
that formerly involved
making a thermoplastic
stent, taking an additional
CBCT scan with a
significant opportunity for
irrecoverable user error,
has become an efficient,
user friendly and easily
repeatable 2 minute
process.
AD
12
28 th EAO Annual Scientific Meeting
Following a brief drill
or implant calibration,
Navident dynamically
presents the deviation
between the actual/
planned position and
orientation of the drill/
implant, guiding the
surgeon to accurately
implement the plan.
accuracy offered by the new version,
combined with the need for minimal
tissue manipulation, is conducive to
a shorter and better recovery process for patients, according to the
company.
Clinicians are invited to learn
from masters and interact with their
peers at ClaroNav’s booth at this
year’s EAO meeting.
ClaroNav, Canada
www.claronav.com
Hall 2, Booth C09
[13] =>
TDI0919_01-16.pdf
PRINT
EVENTS
SERVICES
EDUCATION
DIGITAL
Dental Tribune International
The World's
Dental Marketplace
www.dental-tribune.com
[14] =>
TDI0919_01-16.pdf
travel
What’s on in Lisbon, 26 to 28 September
Belém Tower
• Where: Avenida Brasília
• Opening hours:
Tuesday–Sunday 10:00–18:30
This Lisbon landmark, built in
the sixteenth century on the northern bank of the Tagus river, served as
a fortress and ceremonial gateway to
Lisbon.
It was built during the height of
the Portuguese Renaissance and is a
prominent example of the Portuguese Manueline style but also incorporates hints of other architectural
styles. Thus, both the interior and ex-
terior of the tower offer much to explore and appreciate.
Since 1983, the tower has been a
UNESCO World Heritage Site, along
with the Jerónimos Monastery. It is
often portrayed as a symbol of Europe’s Age of Discovery and as a
metonym for Portugal or Lisbon.
© anyaivanova/Shutterstock.com
Pastel de Belém
• Where:
Pastéis de Belém,
Rua de Belém 84–92
• Opening hours:
Daily 8:00–23:00
• Information:
pasteisdebelem.pt/en/
AD
The Pastéis de Belém bakery
started to make its famous tarts of
flaky pastry and custard in 1837 according to an ancient recipe from
the Jerónimos Monastery. This secret recipe has remained unchanged
ever since and is recreated every
day, by hand, using only traditional
methods. Besides the Pastel de
Belém, the bakery offers other specialities.
© Natalia Mylova/Shutterstock.com
Banksy exhibition
• When: 14 June to 27 October
• Where: Cordoaria Nacional,
Avenida da Ìndia
• Opening hours: Monday–Friday
and Sunday 10:00–19:00 |
Saturday 10:00–20:00
• Information:
www.banksyexhibition.pt/en/
Cordoaria Nacional—which is in
close proximity to the Lisbon congress centre—is hosting the “Banksy:
Genius or Vandal?” exhibition, the
first big display in Portugal of the artist who revolutionised contemporary
art and whose identity remains unknown.
The immersive exhibition features more than 70 creations, lent by
international private collectors and
galleries, and includes original
pieces, sculptures, installations, vid-
14
28 th EAO Annual Scientific Meeting
[15] =>
TDI0919_01-16.pdf
travel
and Technology), O’culto da Ajuda, the
Museu Nacional de Arte Antiga and
the Museu do Oriente. Entry is free.
© SamuelThomas/Shutterstock.com
© amnat30/Shutterstock.com
Santa Casa
Alfama 2019 festival
• When: 27 and 28 September
• Where: Different venues in Alfama
• Information:
www.visitlisboa.com/en/events/
festival-santa-casa-alfama-19
eos and photographs of the artist displayed in different themed areas.
The experience begins with an
audiovisual presentation, specifically
created to welcome visitors to the exhibition, that reveals clues about the
mysterious artist and highlights the
most important pieces. Among the
most recognised works of the exhibition is the original serigraph of the
series Girl with Balloon.
life to be lived and inviting an exploration of the tangible and intangible
components of art and leisure.
Street performances, concerts, traditional theatre and museums, contemporary cinema and digital art are
just some of the art forms marking
this event, which will take place at a
number of venues, including the
MAAT (Museum of Art, Architecture
Santa Casa Alfama is a music festival that celebrates authentic and
traditional Portuguese music. For
two days, Lisbon’s eponymous district is taken over by Fado musicians
and fans of all ages. Fado means “destiny” or “fate” and is a music genre
that can be traced back to the 1820s
in Lisbon, but probably has much
earlier origins. In 2011, Fado was
added to the representative list of
Oral and Intangible Heritage of Humanity by UNESCO.
© BLUR LIVE 1975/Shutterstock.com
European Heritage Days 2019
• When: 27–29 September
• Where: Different venues across
the city
• Information: www.visitlisboa.com/
en/events/european-heritagedays-19
The European Heritage Days
2019 will explore the theme of arts,
heritage and leisure. The theme is intended to highlight the many facets
of heritage linked to the arts, as a
source of entertainment and leisure,
allowing other dimensions of daily
The seventh Santa Casa Alfama
festival, with ten stages and more
than 40 acts, invites music lovers to
experience the traditional sounds of
Portuguese music surrounded by the
beautiful architecture of the oldest
quarter in Lisbon.
The performances take place in a
wide variety of venues, from churches
to museums, at outdoor venues and
recreational associations, and provide visitors with a unique artistic
range of music, worthy of appreciation.
Useful information for the
city of Lisbon
• Time zone: UTC/GMT + 1 hour
• Emergency numbers: Ambulance
service/police: 112
• Currency: Euro
• Tourist information: Rua do Arsenal
15 (Monday–Friday 9:30–19:00)
• Foreign ministry: Portuguese Ministry of Foreign Affairs: www.portaldiplomatico.mne.gov.pt/en/
• Credit card acceptance: Credit
cards like Mastercard and Visa are
widely accepted throughout Portugal. However, it is advisable to
carry some cash, as some restaurants or shops accept only cash or
set a minimum purchase value of
€ 10 for credit card payments.
Additional information for the
EAO congress
• Congress app:
The congress registration fee includes the free download and use of
the congress app. EAO attendees can
use this app to view the programme,
look at individual sessions and
browse abstracts. At the end of the
congress, participants can send themselves an individual visit report, including personal notes and bookmarks. Over the years, the app has become an essential tool for exclusive
scientific content, promoting the congress’s aim of becoming paperless in
the near future.
AD
REGISTER FOR FREE!
DT Study Club – e-learning platform
Join the largest educational network in dentistry!
www.DTStudyClub.com
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP
does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Tribune Group GmbH designates this activity for one continuing education credit.
28 th EAO Annual Scientific Meeting
15
[16] =>
TDI0919_01-16.pdf
Visit us at
booth C15
Surface chemistry cells can’t resist.
Introducing Xeal and TiUltra – two new breakthrough surfaces derived from our decades
of applied anodization expertise. From abutment to implant apex, we have reimagined
surface chemistry and topography to optimize tissue integration at every level.
We’ve now entered the Mucointegration™ era.
The new Xeal surface is now
available for the On1™ Base
and the Multi-unit Abutment.
TiUltra is available on our best
selling NobelActive® and
NobelParallel™ CC implants.
)
[page_count] => 16
[pdf_ping_data] => Array
(
[page_count] => 16
[format] => PDF
[width] => 794
[height] => 1134
[colorspace] => COLORSPACE_UNDEFINED
)
[linked_companies] => Array
(
[ids] => Array
(
)
)
[cover_url] =>
[cover_three] =>
[cover] => ![today EAO Lisbon 27 September 2019]()
[toc] => Array
(
[0] => Array
(
[title] => Nobel Biocare brings latest innovations to Lisbon
[page] => 01
)
[1] => Array
(
[title] => President of Portugal welcomes attendees at EAO 2019
[page] => 02
)
[2] => Array
(
[title] => News
[page] => 03
)
[3] => Array
(
[title] => Floor plan
[page] => 08
)
[4] => Array
(
[title] => List of exhibitors
[page] => 09
)
[5] => Array
(
[title] => Industry
[page] => 10
)
[6] => Array
(
[title] => Travel
[page] => 14
)
)
[toc_html] =>
Table of contents
[toc_titles] => Nobel Biocare brings latest innovations to Lisbon
/ President of Portugal welcomes attendees at EAO 2019
/ News
/ Floor plan
/ List of exhibitors
/ Industry
/ Travel
[cached] => true
)